The CardioClip Study
Part of paid clinical trials in New York, New York.
- Sponsor
- Columbia University
- Study ID
- NCT06241430
- Status
- Recruiting
Conditions
- Heart Failure With Reduced Ejection Fraction
- Mitral Regurgitation
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- CardioMEMS — DEVICEHemodynamic-guided optimization will be performed using the CardioMEMS CardioClip device.
Study Details
The CardioClip study is exploring the use of a wireless sensor to monitor pressure in the pulmonary artery. This sensor is inserted much like the mTEER procedure, a non-surgical method through a vein in the groin. The investigators want to find out if the sensor, by constantly sending information about heart function, can help improve patient outcomes. This means doctors could adjust medications based on real-time pressure changes detected by the sensor. The results from this study will help pave the way for future trials, asking if using these wireless sensors could benefit people with valve disease and heart failure.
Key Dates
- Start date
- Dec 18, 2024
- Status verified
- Jun 2025
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: CardioMemsParticipants randomized to this arm will receive hemodynamic-guided GDMT titration with CardioMems.
- No Intervention: Usual CareParticipants randomized to this arm will receive usual care involving GDMT.
Primary Outcome Measure
The change in Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary (OS) score between baseline (pre-mTEER) and 12 months after mTEER. [ Time Frame: 12 months ]
Central Contacts
- Kate Dalton, MS, RD, CCRC(347) 514-3366
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Columbia University Irving Medical Center / NewYork-Presbyterian Hospital | New York | New York | 10032 | Kate Dalton, MS, RD, CCRC Nir Uriel, MD (PRINCIPAL_INVESTIGATOR) Michael Brener, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
Related Studies
- An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement SystemRecruiting · HighLife SAS · Tucson, Arizona
- The ENCIRCLE TrialRecruiting · Edwards Lifesciences · Huntsville, Alabama
- The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).Recruiting · Mayra Guerrero · Gilbert, Arizona
- Use of Phenylephrine for Assessment of Mitral Regurgitation SeverityPHASE1/PHASE2 · Recruiting · Montefiore Medical Center · New York, New York